CD20 expression, TrkB activation and functional activity of diffuse large B cell lymphoma-derived small extracellular vesicles

Overview of Extracellular Vesicles, Their Origin, Composition, Purpose, and Methods for Exosome Isolation and Analysis

(2019) Laura M. Doyle et al.   Cells

Prohibitin (PHB) expression is associated with aggressiveness in DLBCL and flavagline-mediated inhibition of cytoplasmic PHB functions induces anti-tumor effects

(2019) Hafidha Bentayeb et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

The opportunistic effect of exosomes on Non-Hodgkin Lymphoma microenvironment modulation

(2019) Mara Fernandes et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Extracellular vesicles in DLBCL provide abundant clues to aberrant transcriptional programming and genomic alterations

(2018) Sarah C. Rutherford et al.   BLOOD

Diffuse large B-cell lymphoma

(2018) Shaoying Li et al.   PATHOLOGY

Targeting neurotrophin signaling in cancer: the renaissance

(2018) Nathan Griffin et al.   PHARMACOLOGICAL RESEARCH

Circadian control of BDNF-mediated Nrf2 activation in astrocytes protects dopaminergic neurons from ferroptosis

(2018) Tetsuro Ishii et al.   FREE RADICAL BIOLOGY AND MEDICINE

Exosome-derived miRNAs as predictive biomarkers for diffuse large B-cell lymphoma chemotherapy resistance

(2018) Yuhua Feng et al.   Epigenomics

Anti-apoptotic role and clinical relevance of neurotrophins in diffuse large B-cell lymphomas

(2015) Lydie Dubanet et al.   BRITISH JOURNAL OF CANCER

Nuclear Trapping through Inhibition of Exosomal Export by Indomethacin Increases Cytostatic Efficacy of Doxorubicin and Pixantrone

(2015) R. Koch et al.   CLINICAL CANCER RESEARCH

Exosomes in cancer: small particle, big player

(2015) Xu Zhang et al.   Journal of Hematology & Oncology

Tumor-derived exosomes in cancer progression and treatment failure

(2015) Shaorong Yu et al.   Oncotarget

Biogenesis, Secretion, and Intercellular Interactions of Exosomes and Other Extracellular Vesicles

(2014) Marina Colombo et al.   Annual Review of Cell and Developmental Biology

Expression of B-Cell Surface Antigens in Subpopulations of Exosomes Released From B-Cell Lymphoma Cells

(2014) Morten P. Oksvold et al.   CLINICAL THERAPEUTICS

Inhibitors of SRC kinases impair antitumor activity of anti-CD20 monoclonal antibodies

(2014) Magdalena Winiarska et al.   mAbs

Intercellular Communication by Exosome-Derived microRNAs in Cancer

(2013) Bethany Hannafon et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Exosomes in tumor microenvironment influence cancer progression and metastasis

(2013) Christoph Kahlert et al.   JOURNAL OF MOLECULAR MEDICINE-JMM

Association of CD20 levels with clinicopathological parameters and its prognostic significance for patients with DLBCL

(2012) Yuhko Suzuki et al.   ANNALS OF HEMATOLOGY

Comparison of CD20 expression in B-cell lymphoma between newly diagnosed, untreated cases and those after rituximab treatment

(2012) Hiroaki Miyoshi et al.   CANCER SCIENCE

Rituximab resistance

(2011) Andrew R. Rezvani et al.   BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY

Endogenous Neurotrophins and Trk Signaling in Diffuse Large B Cell Lymphoma Cell Lines Are Involved in Sensitivity to Rituximab-Induced Apoptosis

(2011) Cynthia Bellanger et al.   PLoS One

Exosomal evasion of humoral immunotherapy in aggressive B-cell lymphoma modulated by ATP-binding cassette transporter A3

(2011) T. Aung et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Aggressive Lymphomas

(2010) Georg Lenz et al.   NEW ENGLAND JOURNAL OF MEDICINE

A selective TrkB agonist with potent neurotrophic activities by 7,8-dihydroxyflavone

(2010) S.-W. Jang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Down-regulation of CD20 expression in B-cell lymphoma cells after treatment with rituximab-containing combination chemotherapies: its prevalence and clinical significance

(2009) J. Hiraga et al.   BLOOD

Diffuse large B-cell lymphoma: reduced CD20 expression is associated with an inferior survival

(2008) N. A. Johnson et al.   BLOOD

Acquirement of Rituximab Resistance in Lymphoma Cell Lines Is Associated with Both Global CD20 Gene and Protein Down-Regulation Regulated at the Pretranscriptional and Posttranscriptional Levels

(2008) M. S. Czuczman et al.   CLINICAL CANCER RESEARCH